BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6641103)

  • 21. [Results of a clinical trial with ambroxol as to postoperative therapy of bronchitis (author's transl)].
    Kranicke R
    Arzneimittelforschung; 1978; 28(5a):934-5. PubMed ID: 581994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect on the mucociliary clearance of ambroxol administered via inhalation: preliminary observations].
    Olivieri D; Del Donno M; Annicelli A; Palmieri F
    Arch Monaldi; 1983; 38(4):135-40. PubMed ID: 6679252
    [No Abstract]   [Full Text] [Related]  

  • 23. [Incorporation of a stimulant of the synthesis and secretion of pulmonary surfactant (ambroxol) in the medical treatment of serous otitis].
    Calero del Castillo JB; Pérez Martínez F; Piqueras Pérez F; Redondo Luciáñez ER
    An Otorrinolaringol Ibero Am; 1988; 15(2):209-18. PubMed ID: 3389499
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the therapy of cough in bronchial diseases of children].
    Palumbo-Vargas O
    Minerva Med; 1971 Feb; 62(17):833-6. PubMed ID: 5551771
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prophylaxis and treatment of bronchopulmonary complications with ambroxol administered by infusion in elderly patients undergoing surgery].
    Bavaro P; Biscari P
    G Chir; 1989 Oct; 10(10):605-9. PubMed ID: 2518303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacology of ambroxol--review and new results.
    Disse BG
    Eur J Respir Dis Suppl; 1987; 153():255-62. PubMed ID: 3322865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of the effects of ambroxol in the surgical preparation of patients with bronchopulmonary disorders. Administration during intermittent positive pressure ventilation].
    Minuto A; Corino T; Ceccopieri M; Bardi F
    Clin Ter; 1984 Dec; 111(6):521-30. PubMed ID: 6396029
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of lasolvan on the rheologic properties of sputum].
    Chuchalin AG; Solopov VN; Kolganova NA; Plisko LF
    Klin Med (Mosk); 1987 Mar; 65(3):52-4. PubMed ID: 3298838
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapeutic activity of ambroxol theophyllinacetate in chronic obstructive pulmonary diseases.
    Primbs K
    Clin Ther; 1985; 7(6):733-6. PubMed ID: 4075364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo.
    Olivieri D; Zavattini G; Tomasini G; Daniotti S; Bonsignore G; Ferrara G; Carnimeo N; Chianese R; Catena E; Marcatili S
    Respiration; 1987; 51 Suppl 1():42-51. PubMed ID: 3299567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ambroxol and simple chronic bronchitis. Effects on subjective symptoms and ventilatory function.
    Ericsson CH; Juhasz J; Jönsson E; Mossberg B
    Respiration; 1987; 51 Suppl 1():33-6. PubMed ID: 3299565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of secretory otitis media with ambroxol].
    Sartoris A
    Acta Otorhinolaryngol Ital; 1987; 7 Suppl 16():51-60. PubMed ID: 3334304
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of ambroxol on mucociliary clearance (author's transl)].
    Weiss T; Dorow P; Felix R
    Prax Klin Pneumol; 1981 Aug; 35(8):359-62. PubMed ID: 7345432
    [No Abstract]   [Full Text] [Related]  

  • 34. [Long-term therapy over 2 years with ambroxol (Mucosolvan) retard capsules in patients with chronic bronchitis. Results of a double-blind study of 180 patients].
    Cegla UH
    Prax Klin Pneumol; 1988 Sep; 42(9):715-21. PubMed ID: 3141915
    [No Abstract]   [Full Text] [Related]  

  • 35. [Value of ambroxol in treatment of bronchial asthma and spastic bronchitis].
    Siergiejko Z; Obrzut D; Rogalewska A
    Pol Tyg Lek; 1991 May 27-Jun 3; 46(22-23):424-7. PubMed ID: 1669082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The use of guacetisal in bronchopulmonary pathology in children].
    Baggio S; Buonomo A
    Minerva Pediatr; 1983 Feb; 35(3):129-33. PubMed ID: 6843529
    [No Abstract]   [Full Text] [Related]  

  • 37. [Eprozinol treatment of chronic bronchitis with dyspnea and cough].
    Nicrosini F; Carpinella G
    Bronchopneumologie; 1978; 28(4):322-7. PubMed ID: 756799
    [No Abstract]   [Full Text] [Related]  

  • 38. [RDS prevention by prednilyden and ambroxol. A comparative study].
    Geibel W; Rindt W; Becker H
    Arch Gynecol; 1979 Jul; 228(1-4):204. PubMed ID: 582652
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical use of the combination prenoxidiazine-S-carboxy-methyl-cysteine].
    Alesina R; Caliandro L; Cerveri I; Scala C
    G Clin Med; 1979 Feb; 60(2):136-54. PubMed ID: 378746
    [No Abstract]   [Full Text] [Related]  

  • 40. Improvement of mucociliary transport in smokers by mucolytics.
    Olivieri D; Marsico SA; Del Donno M
    Eur J Respir Dis Suppl; 1985; 139():142-5. PubMed ID: 3862608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.